Skip to content

Phacoemulsification and Intraocular Lens Implantation: Patient Registry

Phacoemulsification and Intraocular Lens Implantation: Patient Registry

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07276217
Enrollment
300
Registered
2025-12-10
Start date
2025-01-02
Completion date
2026-07-31
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Intraocular Lens

Keywords

cataract, intraocular lens, phacoemulsification

Brief summary

The aim of the study is to create a patient registry that will allow for comparison of cataract treatment outcomes using phacoemulsification with implantation of different types of intraocular lenses.

Detailed description

This study will establish a registry to evaluate outcomes associated with intraocular lens implants in patients undergoing cataract surgery. Retrospective assessments will include routinely collected preoperative, intraoperative, and postoperative data. Prospectively, visual acuity, refraction, examination findings, patient-reported outcomes, and complications will be collected for up to 60 months after surgery.

Interventions

DEVICEIntraocular lens

Implantation of an intraocular lens following phacoemulsification cataract extraction, with lens type selected according to routine clinical practice (e.g., monofocal, toric, multifocal, or extended-depth-of-focus).

Sponsors

Sensor Cliniq
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who have undergone cataract surgery or are scheduled for bilateral cataract surgery with implantation of an extended-depth-of-focus (EDOF) intraocular lens, a monofocal-plus intraocular lens, or a standard monofocal intraocular lens.

Exclusion criteria

* Anterior or posterior segment pathologies affecting postoperative visual acuity, including but not limited to: severe dry eye syndrome, corneal dystrophies, uveitis, retinal degenerative changes, glaucoma, or diabetic retinopathy. * Pseudoexfoliation syndrome * Keratoconus * History of laser refractive surgery * Prior ocular surgery other than cataract surgery * Amblyopia * Posterior capsule opacification * Postoperative best-corrected visual acuity (BCVA) less 0.5 * Intraoperative complications, including posterior capsule rupture

Design outcomes

Primary

MeasureTime frameDescription
Corrected and Uncorrected Distance, Intermediate and Near Visual AcuityMeasured at the follow-up visit up to 60 months after cataract surgeryDistance, intermediate, and near visual acuity will be measured both uncorrected and corrected using standard ETDRS charts at 4 meters for distance, 66 cm for intermediate, and 40 cm for near visual acuity.

Secondary

MeasureTime frameDescription
Subjective RefractionMeasured at the follow-up visit up to 60 months after cataract surgerySpherical and cylindrical refractive errors will be measured subjectively using trial frame glasses and patient responses.
Monocular and Binocular Defocus CurveMeasured at the follow-up visit up to 60 months after cataract surgeryVisual acuity will be measured at varying defocus levels under monocular and binocular conditions to assess the range of functional vision. Measurements will be taken in 0.5 D steps from +1.00 D to -2.50 D.
Contrast SensitivityMeasured at the follow-up visit up to 60 months after cataract surgeryContrast sensitivity will be assessed using the Matrix Perceptix test under photopic light conditions.
KeratometryMeasured at the follow-up visit up to 60 months after cataract surgeryKeratometry will be measured using IOLMaster 500 and Pentacam
Anterior Chamber DepthMeasured at the follow-up visit up to 60 months after cataract surgeryAnterior chamber depth will be measured using IOLMaster 500 and Pentacam.
Objective RefractionMeasured at the follow-up visit up to 60 months after cataract surgerySpherical and cylindrical refractive errors will be measured objectively using an autorefractometer.
Central Corneal ThicknessMeasured at the follow-up visit up to 60 months after cataract surgeryCentral corneal thickness will be measured using Pentacam.
Anterior Chamber AngleMeasured at the follow-up visit up to 60 months after cataract surgeryAnterior chamber angle will be measured using Pentacam.
Primary and Secondary Spherical AberrationsMeasured at the follow-up visit up to 60 months after cataract surgeryPrimary and secondary spherical aberrations will be measured using Pentacam.
Patient-Reported Spectacle IndependenceMeasured at the follow-up visit up to 60 months after cataract surgeryDegree of spectacle independence will be assessed using the Patient-Reported Spectacle Independence Questionnaire (PRSIQ).
Patient-Reported Quality of VisionMeasured at the follow-up visit up to 60 months after cataract surgeryQuality of vision will be assessed using the Quality of Vision Questionnaire (QoV).
Pupil SizeMeasured at the follow-up visit up to 60 months after cataract surgeryPupil diameter will be measured using IOLMaster 500 and Pentacam.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026